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Abstract
Guillain-Barre syndrome (GBS) is preceded by a respiratory or gastrointestinal illness in more
than 50% of the patients. A rare association of GBS with a preceding snakebite is reported in
the literature in only four previous cases. We present a case report of a patient diagnosed with
GBS following the bite of a yellow-bellied sea snake (Hydrophis platurus) and a brief review of
the available literature.
Categories: Neurology
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Introduction
Guillain-Barre syndrome (GBS) is an acute-onset acquired polyneuropathy with an annual
incidence of 0.5-2 cases per 100,000 [1]. More than half of the patients have a history of
preceding respiratory or gastrointestinal illness. An association of GBS with preceding
snakebite is rare and has been reported in the literature in only four previous cases. We present
a case of GBS following snakebite and a brief review of the available literature.
Case Presentation
A 21-year-old male, fisherman by profession, presented with a three-week history of
progressive generalized weakness, diplopia, decreased appetite and lethargy with difficulty in
performing activities of his daily living. For the past three days, he was having a high-grade
fever and shortness of breath. He was managed in the medicine department with the diagnosis
of aspiration pneumonia with type-1 respiratory failure. The patient reported that six weeks
ago, he was bitten by a yellow-bellied sea snake (Hydrophis platurus) on his left palm during
fishing. No anti-venom was administered at that time. Neurology team was consulted on the
second day of admission.
On physical examination, he had a blood pressure of 90/60 mmHg, a pulse of 85 per minute and
a temperature of 98.2 F. He was on continuous non-invasive ventilation (NIV) support for his
hypoxia. He had a well-demarcated clean healing wound of around 2-cm in diameter on his left
palm. He was awake and oriented with intact higher mental functions. Pupils were of 3-mm
bilaterally and reactive to light and accommodation. Right lateral rectus palsy was noted. There
was no facial muscle weakness and tongue was central on protrusion. His speech had a hyper-
nasal quality. Movements of soft palate and uvula were absent on testing with an absent gag
reflex. On motor examination, he had normal bulk without fasciculation. Muscle tone was
mildly reduced in all limbs. In both upper limbs, he had muscle strength of Medical Research
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Council (MRC) grade 3/5 in proximal muscle groups and MRC grade 4/5 in distal muscle groups,
while in lower limbs he had MRC grade of 4/5 in both proximal and distal muscle groups. Deep
tendon reflexes were absent in all four limbs. Sensory examination was unremarkable.
Investigations
Initial laboratory investigations (on day one) are shown in Table 1. 
Test Result Reference
Hemoglobin 15.6 g/dL 12.3 - 16.6 g/dL
White blood cell count 18.2 x 10E9/L 4.8-11.3 x 10E9/L
Neutrophils 85.8 % 34.9 - 76.2 %
Lymphocytes 4.4 % 17.5 - 45 %
Platelet count 544 x 10E9/L 154 - 433 x 10E9/L
Procalcitonin 1.67 ng/mL Positive > 2.0 ng/mL
Magnesium 1.8 mg/dL 1.6 - 2.6 mg/dL
Blood urea nitrogen 32 mg/dL 6 - 20 mg/dL
Creatinine 1.3 mg/dL 0.9 - 1.3 mg/dL
Sodium 140 mmol/L 136 - 145 mmol/L
Potassium 3.8 mmol/L 3.5 - 5.1 mmol/L
Chloride 97 mmol/L 98 – 107 mmol/L
Bicarbonate 33.1 mmol/L 20 – 31 mmol/L
Calcium 9.6 mg/dL 8.6 - 10.2 mg/dL
Erythrocyte sedimentation rate 95 mm/1st hour 0-15 mm/1st hour
C-reactive protein 15.59 mg/dL 0 – 0.5 mg/dL
TABLE 1: Laboratory investigations
Our differential diagnosis indicated either a brainstem stroke or demyelination. Cranial
magnetic resonance imaging (MRI) was negative for an acute brainstem stroke or abnormal
contrast enhancement (Figure 1).
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FIGURE 1: MRI Brain: No acute ischemic stroke on DWI
sequences (Figure 1A, 1B). No abnormal signals on pre-
contrast ( Figure 1C) or post-contrast FLAIR sequence (Figure
1D). Red arrows indicate brainstem, which is normal
MRI = Magnetic resonance imaging; DWI = Diffusion-weighted imaging; FLAIR = Fluid-attenuated
inversion recovery
On the third day of admission, electromyography and nerve conduction studies (EMG/NCS)
were performed. These revealed normal sensory nerve conduction, while motor amplitudes of
the bilateral peroneal, right median, and ulnar nerves were reduced without a conduction block.
In the clinical context, the patient was diagnosed with an acute motor axonal neuropathy
(AMAN) variant of GBS.
Management
The patient was initially managed with continuous NIV and broad-spectrum antibiotics for
aspiration pneumonia.
On the third day of admission, plasmapheresis was initiated after obtaining the EMG/NCS
results. The decision of plasmapheresis over IVIG was made based on the patient's preference.
Vital capacity was monitored regularly. After the third session of plasmapheresis (on day five),
he developed severe respiratory distress and SaO2 dropped to 65% despite NIV following which
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he was intubated. The remaining two sessions of plasmapheresis were done in the intensive-
care unit (ICU). On the seventh day of admission, the final (fifth) session of plasmapheresis was
done. On day nine, the patient was extubated.
From days 9-14, the patient underwent regular inpatient physiotherapy and rehabilitation. On
day 14, he was discharged home in a stable condition with a nasogastric tube (NGT) in place.
Follow-up
The patient was stable on the first follow up at the clinic (after three weeks of being discharged
from the hospital). The NGT was removed and he was taking food orally. Muscle strength was
of MRC grade 3/5 in all four limbs. Right lateral rectus palsy was present.
On the second clinic follow up (after four months of being discharged from the hospital), the
patient regained his muscle strength to MRC grade 5/5 in all four limbs and was ambulating
without difficulty. The right lateral palsy persisted.
Discussion
Guillain-Barre syndrome is an acute autoimmune-mediated polyneuropathy that commonly
presents with bilateral symmetrical ascending flaccid paralysis. However, variations in the
clinical presentation of GBS do exist, as in our case. About 70% of patients with GBS have a
preceding event, most commonly a respiratory or gastrointestinal illness. Additionally, GBS is
reported to be associated with surgery, cancer, and vaccines [1]. Only a few case reports suggest
an association of a snakebite with GBS [2-4].
In 1996, Chuang et al. reported the first case of GBS in association with a snakebite [2]. The
patient presented with progressive quadriparesis, autonomic dysfunction, and cerebrospinal
fluid (CSF) cytoalbuminologic dissociation, four weeks after the bite of a Formosan krait
(Bungarus multicinctus). EMG/NCS revealed sensorimotor axonal-type polyneuropathy. The
patient improved with subsequent treatment (plasmapheresis and methylprednisolone of 500
mg/day for five days) and rehabilitation.
The second case was reported by Srivastava et al. in 2010 [3]. In this case, the patient presented
with bilateral paresthesia in the upper limbs and quadriparesis five weeks after the snakebite.
The snake species could not be identified. EMG/NCS revealed motor and sensory neuropathy-
primarily suggestive of demyelination with secondary axonal degeneration. The patient
improved with plasmapheresis.
In 2011, Neil et al. [4] reported the third case of GBS following the bite of the snake,  Vipera
aspis. The patient presented with paraesthesia and quadriparesis after 12 days of snakebite. The
authors went one step further and demonstrated cross-reactivity between venom proteins and
neuronal GM2 gangliosides (molecular mimicry), postulating a potential immunological basis
for this association rather than direct venom toxicity.
The fourth case was reported in 2014 by Neto et al. from Brazil [5]. In this case, the patient
presented with quadriparesis and areflexia following the bite of Rattlesnake (Crotalus sp.) two
weeks back. The patient improved with intravenous immunoglobulin (IVIG) and rehabilitation.
EMG/NCS performed on follow-up (on the 60th day) was consistent with sensory and motor
axonal polyradiculoneuropathy.
To the best of our knowledge, this is the fifth case of GBS associated with a snakebite. All the
patients presented later, from 12 days [5] to five weeks [3], following the snake bite indicating
2019 Hameed et al. Cureus 11(7): e5278. DOI 10.7759/cureus.5278 4 of 6
an immune-related etiology rather than direct effects of the toxin, as suggested by Neil et al.
[4]. Another possibility was that the anti-venom may be associated with GBS rather than the
snake venom itself. However, two of the patients, including ours, didn’t receive the anti-venom
[4]. All the patients improved with treatment and were able to perform activities of daily living
on follow-up visits. One patient received IVIG and three patients received plasmapheresis, out
of which one also received additional methylprednisolone. The treatment of the remaining
patient is unknown. Both IVIG and plasmapheresis are equally effective in the treatment of
GBS, while steroids have no proven role [1].
Our case was slightly different in that the snake was native to water and the polyneuropathy
was of pure motor type (AMAN variant of GBS), while all other cases presented with mixed
sensorimotor polyneuropathies. All the previous case reports have been summarized in Table 2.
Authors
(Country
& year)
Snake
species Clinical features
Time duration
from snakebite
to
Presentation 
Antivenom
received EMG/NCS Treatment
Chuang et
al. [2]
(Taiwan,
1996)
Formosan
krait
(Bungarus
multicinctus)
Quadriparesis, facial
weakness, and
autonomic
dysfunction
Four weeks Yes Sensorimotor axonal-typepolyneuropathy.  
Plasmapheresis;
Methylprednisolone,
500 mg/d for five
days
Srivastava
et al. [3]
(India,
2010)  
---
Quadriparesis and
paresthesia in upper
limbs.
Five weeks Yes
Sensorimotor polyneuropathy—
primarily suggestive of
demyelination with secondary
axonal degeneration.
Plasmapheresis
Neil et al.
[4]
(France,
2011)
Viper (Vipera
Aspis)
Paresthesia in all four
extremities, gait
ataxia, and
quadriparesis
12 days No
Sensorimotor polyneuropathy -
primarily suggestive of
demyelination with conduction
block
----
Neto et al.
[5] (Brazil,
2014)
Rattlesnake
(Crotalus
sp.)
Quadriparesis Two weeks Yes Sensorimotor axonalpolyradiculoneuropathy. IVIG
TABLE 2: Case reports of Guillain-Barre syndrome following snake bite.
EMG/NCS = Electromyography and nerve conduction studies; IVIG = intravenous immune globulin
Snakebite is a common condition, but a neglected one [6]. Although exact data is lacking, the
annual estimates vary from 4.5 to 5.4 million snakebites, 1.8 to 2.7 million envenomings, and
81,000 to 138,000 deaths according to the World Health Organization [7]. Despite these huge
numbers, only a handful of cases of GBS following snakebite are reported in the literature. We
can assume that many cases would have been missed due to under-reporting. Nonetheless,
further studies are needed to confirm the association between GBS following a snakebite.
Conclusions
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The temporal association of the snakebite with GBS in all the aforementioned cases suggest a
possible association. Patients with a snakebite should be observed for new-onset flaccid
weakness for multiple weeks and if present, it should be addressed urgently. The prognosis is
excellent if timely interventions are performed.
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